Foghorn Historical Financial Ratios

FHTX Stock  USD 7.79  0.27  3.59%   
Foghorn Therapeutics is recently reporting on over 95 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 66.4 K or Invested Capital of 0.0 will help investors to properly organize and evaluate Foghorn Therapeutics financial condition quickly.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Foghorn Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Foghorn Stock please use our How to Invest in Foghorn Therapeutics guide.

About Foghorn Financial Ratios Analysis

Foghorn TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Foghorn Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Foghorn financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Foghorn Therapeutics history.

Foghorn Therapeutics Financial Ratios Chart

At this time, Foghorn Therapeutics' ROIC is fairly stable compared to the past year. Payables Turnover is likely to rise to 18.40 in 2024, whereas Price To Sales Ratio is likely to drop 7.53 in 2024.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Foghorn Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Foghorn Therapeutics sales, a figure that is much harder to manipulate than other Foghorn Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Stock Based Compensation To Revenue

A metric that compares the total value of stock-based compensation granted by a company to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards.

Inventory Turnover

A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.

Ev To Free Cash Flow

A valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued.
Most ratios from Foghorn Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Foghorn Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Foghorn Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Foghorn Stock please use our How to Invest in Foghorn Therapeutics guide.At this time, Foghorn Therapeutics' ROIC is fairly stable compared to the past year. Payables Turnover is likely to rise to 18.40 in 2024, whereas Price To Sales Ratio is likely to drop 7.53 in 2024.
 2023 2024 (projected)
Graham Number9.859.63
Receivables Turnover0.0039570.003518

Foghorn Therapeutics fundamentals Correlations

-0.50.68-0.2-0.03-0.190.680.63-0.51.0-0.210.420.91-0.570.99-0.71-0.86-0.84-0.33-0.89-0.470.350.49-0.84-0.98-0.39
-0.50.10.180.860.940.1-0.31.0-0.50.95-0.97-0.46-0.14-0.460.920.60.330.190.651.0-0.96-1.00.550.520.2
0.680.10.120.550.41.00.410.10.680.39-0.190.5-0.780.63-0.13-0.62-0.57-0.22-0.650.12-0.3-0.1-0.64-0.68-0.2
-0.20.180.120.210.220.120.440.18-0.210.18-0.23-0.570.34-0.280.39-0.250.29-0.71-0.050.15-0.37-0.17-0.320.280.41
-0.030.860.550.210.980.55-0.020.86-0.040.98-0.89-0.12-0.53-0.030.660.15-0.050.040.180.87-0.94-0.860.10.060.05
-0.190.940.40.220.980.4-0.070.94-0.191.0-0.94-0.23-0.38-0.170.780.310.080.050.350.95-0.98-0.940.250.220.12
0.680.11.00.120.550.40.410.10.680.39-0.190.5-0.780.63-0.13-0.62-0.57-0.22-0.650.12-0.3-0.1-0.64-0.68-0.2
0.63-0.30.410.44-0.02-0.070.41-0.30.63-0.130.280.420.070.64-0.24-0.76-0.37-0.92-0.57-0.290.110.3-0.78-0.510.14
-0.51.00.10.180.860.940.1-0.3-0.50.95-0.97-0.46-0.14-0.460.920.60.330.190.651.0-0.96-1.00.550.520.2
1.0-0.50.68-0.21-0.04-0.190.680.63-0.5-0.210.420.91-0.570.99-0.71-0.86-0.84-0.33-0.89-0.470.360.49-0.83-0.98-0.39
-0.210.950.390.180.981.00.39-0.130.95-0.21-0.94-0.23-0.4-0.180.780.340.090.110.370.95-0.97-0.950.290.230.1
0.42-0.97-0.19-0.23-0.89-0.94-0.190.28-0.970.42-0.940.440.20.4-0.85-0.51-0.16-0.16-0.55-0.960.960.97-0.44-0.460.0
0.91-0.460.5-0.57-0.12-0.230.50.42-0.460.91-0.230.44-0.540.95-0.71-0.6-0.79-0.05-0.68-0.430.430.46-0.55-0.91-0.44
-0.57-0.14-0.780.34-0.53-0.38-0.780.07-0.14-0.57-0.40.2-0.54-0.520.20.330.52-0.340.5-0.170.230.150.310.660.31
0.99-0.460.63-0.28-0.03-0.170.630.64-0.460.99-0.180.40.95-0.52-0.68-0.78-0.84-0.32-0.81-0.430.350.45-0.76-0.95-0.41
-0.710.92-0.130.390.660.78-0.13-0.240.92-0.710.78-0.85-0.710.2-0.680.660.610.040.770.91-0.88-0.920.610.750.44
-0.860.6-0.62-0.250.150.31-0.62-0.760.6-0.860.34-0.51-0.60.33-0.780.660.620.60.960.59-0.38-0.60.990.840.16
-0.840.33-0.570.29-0.050.08-0.57-0.370.33-0.840.09-0.16-0.790.52-0.840.610.620.160.670.31-0.24-0.320.630.80.81
-0.330.19-0.22-0.710.040.05-0.22-0.920.19-0.330.11-0.16-0.05-0.34-0.320.040.60.160.370.21-0.01-0.20.650.18-0.21
-0.890.65-0.65-0.050.180.35-0.65-0.570.65-0.890.37-0.55-0.680.5-0.810.770.960.670.370.63-0.45-0.650.940.910.26
-0.471.00.120.150.870.950.12-0.291.0-0.470.95-0.96-0.43-0.17-0.430.910.590.310.210.63-0.96-1.00.540.50.19
0.35-0.96-0.3-0.37-0.94-0.98-0.30.11-0.960.36-0.970.960.430.230.35-0.88-0.38-0.24-0.01-0.45-0.960.96-0.31-0.39-0.22
0.49-1.0-0.1-0.17-0.86-0.94-0.10.3-1.00.49-0.950.970.460.150.45-0.92-0.6-0.32-0.2-0.65-1.00.96-0.55-0.52-0.2
-0.840.55-0.64-0.320.10.25-0.64-0.780.55-0.830.29-0.44-0.550.31-0.760.610.990.630.650.940.54-0.31-0.550.80.18
-0.980.52-0.680.280.060.22-0.68-0.510.52-0.980.23-0.46-0.910.66-0.950.750.840.80.180.910.5-0.39-0.520.80.38
-0.390.2-0.20.410.050.12-0.20.140.2-0.390.10.0-0.440.31-0.410.440.160.81-0.210.260.19-0.22-0.20.180.38
Click cells to compare fundamentals

Foghorn Therapeutics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Foghorn Stock Analysis

When running Foghorn Therapeutics' price analysis, check to measure Foghorn Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foghorn Therapeutics is operating at the current time. Most of Foghorn Therapeutics' value examination focuses on studying past and present price action to predict the probability of Foghorn Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foghorn Therapeutics' price. Additionally, you may evaluate how the addition of Foghorn Therapeutics to your portfolios can decrease your overall portfolio volatility.